Laboratorios Farmaceuticos Rovi (XMAD:ROVI) Inventories, Raw Materials & Components: €0.0 Mil (As of Mar. 2026)


XMAD:ROVI Laboratorios Farmaceuticos Rovi SA XMAD:ROVI
97 GF Score
Price €57.50
GF Value €50.98
Valuation Modestly Overvalued
! 1 Warning Sign
View Full Analysis

What is Laboratorios Farmaceuticos Rovi Inventories, Raw Materials & Components?

Laboratorios Farmaceuticos Rovi XMAD:ROVI -0.61% 97 Inventories, Raw Materials & Components is €0.0 Mil as of Mar. 2026. GuruFocus rates XMAD:ROVI with a GF Score™ of 97/100 and a GF Value™ of €50.98 (Modestly Overvalued). The stock has 1 warning sign investors should review.

Laboratorios Farmaceuticos Rovi's inventories, raw materials & components for the quarter that ended in Mar. 2026 was €0.0 Mil.

Laboratorios Farmaceuticos Rovi's quarterly raw materials increased from Sep. 2025 (€0.0 Mil) to Dec. 2025 (€102.8 Mil) but then declined from Dec. 2025 (€102.8 Mil) to Mar. 2026 (€0.0 Mil).

Laboratorios Farmaceuticos Rovi's annual raw materials declined from Dec. 2023 (€169.4 Mil) to Dec. 2024 (€106.2 Mil) and declined from Dec. 2024 (€106.2 Mil) to Dec. 2025 (€102.8 Mil).

Laboratorios Farmaceuticos Rovi Inventories, Raw Materials & Components Historical Data

* Premium members only.

The historical data trend for Laboratorios Farmaceuticos Rovi's Inventories, Raw Materials & Components can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Laboratorios Farmaceuticos Rovi Inventories, Raw Materials & Components Chart

Laboratorios Farmaceuticos Rovi Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Inventories, Raw Materials & Components
Get a 7-Day Free Trial Premium Member Only Premium Member Only 124.94 159.03 169.37 106.19 102.79

Laboratorios Farmaceuticos Rovi Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Inventories, Raw Materials & Components Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 104.60 0.00 102.79 0.00
XMAD:ROVI
97GF Score
Laboratorios Farmaceuticos Rovi SA XMAD:ROVI
Inventories, Raw Materials & Components is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Laboratorios Farmaceuticos Rovi Inventories, Raw Materials & Components Calculation

Materials and components scheduled for use in making a product.

What does a Inventories, Raw Materials & Components of €0.0 Mil mean?
Laboratorios Farmaceuticos Rovi (XMAD:ROVI) has a Inventories, Raw Materials & Components of €0.0 Mil as of Mar. 2026. Raw materials are the components a company uses for its main products. View historical data on Laboratorios Farmaceuticos Rovi and its competitors.
Is Laboratorios Farmaceuticos Rovi's Inventories, Raw Materials & Components too high?
Laboratorios Farmaceuticos Rovi's current Inventories, Raw Materials & Components is €0.0 Mil. Overall, Laboratorios Farmaceuticos Rovi has a GF Score™ of 97/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Laboratorios Farmaceuticos Rovi's Inventories, Raw Materials & Components compare to ZTS and UTHR?
Laboratorios Farmaceuticos Rovi's Inventories, Raw Materials & Components of €0.0 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Inventories, Raw Materials & Components for a Drug Manufacturers company?
A good Inventories, Raw Materials & Components depends on the Drug Manufacturers industry context. However, Inventories, Raw Materials & Components should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Inventories, Raw Materials & Components mean?
A high Inventories, Raw Materials & Components can signal that a stock is expensive relative to its fundamentals. Raw materials are the components a company uses for its main products. View historical data on Laboratorios Farmaceuticos Rovi and its competitors. Laboratorios Farmaceuticos Rovi's current Inventories, Raw Materials & Components is €0.0 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Laboratorios Farmaceuticos Rovi stock overvalued right now?
Based on GuruFocus' analysis, Laboratorios Farmaceuticos Rovi (XMAD:ROVI) is currently considered Modestly Overvalued. The stock's GF Value™ is €50.98, compared to a current price of €57.50 — trading 12.8% above its estimated fair value. The current Inventories, Raw Materials & Components is €0.0 Mil. Laboratorios Farmaceuticos Rovi's overall GF Score™ is 97/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Inventories, Raw Materials & Components calculated?
Inventories, Raw Materials & Components is calculated from a company's financial statements. For Laboratorios Farmaceuticos Rovi (XMAD:ROVI), the current Inventories, Raw Materials & Components is €0.0 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Laboratorios Farmaceuticos Rovi (XMAD:ROVI) Overvalued in 2026?

Based on GuruFocus' analysis, Laboratorios Farmaceuticos Rovi stock appears to be overvalued. The current stock price of €57.50 is trading 12.8% above its estimated GF Value™ of €50.98. GuruFocus considers Laboratorios Farmaceuticos Rovi to be Modestly Overvalued.

Key valuation signals for XMAD:ROVI:

  • Inventories, Raw Materials & Components: €0.0 Mil
  • GF Value™: €50.98 vs. price of €57.50 (12.8% above fair value)
  • GF Score™: 97/100 with 1 warning sign

No single metric tells the full story. See the XMAD:ROVI stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Laboratorios Farmaceuticos Rovi Business Description

Address Julian Camarillo, 35, Madrid, ESP, 28037
Laboratorios Farmaceuticos Rovi SA is a biotechnology company engaged in the research, development, manufacturing, and marketing of small molecule and specialty biologic drugs. The company has a diversified portfolio of products that it markets in Spain through its specialized sales force of specialist physicians, hospitals and pharmacies. Laboratorios' research and development pipeline is focused on the expansion of applications, indications, and alternative mechanisms of action for heparin-derived products. The company aims to obtain new pharmaceutical products that enable the regular administration of formulations that are administered daily in chronic and prolonged treatments. Its two segments are Manufacturing and Marketing.
97GF Score

Get the complete analysis for XMAD:ROVI

Inventories, Raw Materials & Components is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€57.50
Price
€50.98
GF Value